A dual agonist of TLR7 and TLR8
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

CL097

Item No. 39513

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
2-(ethoxymethyl)-3H-imidazo[4,5-c]quinolin-4-amine
CAS Number
1026249-18-2
Molecular Formula
C13H14N4O
Formula Weight
242.3
Purity
≥98%
Formulation (Request formulation change)
A solid
Solubility(Learn about Variance in Solubility)
DMSO: soluble
λmax
248, 322 nm
SMILES
NC1=NC2=CC=CC=C2C3=C1N=C(COCC)N3
InChi Code
InChI=1S/C13H14N4O/c1-2-18-7-10-16-11-8-5-3-4-6-9(8)15-13(14)12(11)17-10/h3-6H,2,7H2,1H3,(H2,14,15)(H,16,17)
InChi Key
DEVCLHVFELRPIU-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    1 mg

    $33

    Add

    5 mg

    $98

    Add

    10 mg

    $181

    Add

    25 mg

    $409

    Add
    Cayman Chemical
    Explore Obesity & Metabolic Disease Resources

    Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.

    OBESITY RESEARCH SOLUTIONS
    Product Description

    CL097 is a dual agonist of toll-like receptor 7 (TLR7) and TLR8.1 It induces activation of NF-κB in HEK293 cells expressing human TLR7 or TLR8 when used at concentrations of 0.1 and 1 µg/ml, respectively. CL097 induces TNF-α production and enhances LPS- or hyaluronic acid-induced TNF-α, IL-10, and IL-12 production in isolated human monocyte-derived macrophages.2 In vivo, CL097 (5 mg/kg) increases pancreatic lymph node IFN-α levels in pre-diabetic non-obese diabetic (NOD) mice.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Schön, M.P., and Schön, M. TLR7 and TLR8 as targets in cancer therapy. Oncogene 27(2), 190-199 (2008).

    2. Petricevic, B., Wessner, B., Sachet, M., et al. CL097, a TLR7/8 ligand, inhibits TLR-4–dependent activation of IRAK-M and BCL-3 expression. Shock 32(5), 484-490 (2009).

    3. Lee, A.S., Ghoreishi, M., Cheng, W.K., et al. Toll-like receptor 7 stimulation promotes autoimmune diabetes in the NOD mouse. Diabetologia 54(6), 1407-1416 (2011).